136 related articles for article (PubMed ID: 36934885)
1. Thermal stability of exenatide encapsulated in stratified dissolving microneedles during storage.
Liu H; Wang B; Xing M; Meng F; Zhang S; Yang G; Cheng A; Yan C; Xu B; Gao Y
Int J Pharm; 2023 Apr; 636():122863. PubMed ID: 36934885
[TBL] [Abstract][Full Text] [Related]
2. Rapidly dissolvable microneedle patches for transdermal delivery of exenatide.
Zhu Z; Luo H; Lu W; Luan H; Wu Y; Luo J; Wang Y; Pi J; Lim CY; Wang H
Pharm Res; 2014 Dec; 31(12):3348-60. PubMed ID: 24867426
[TBL] [Abstract][Full Text] [Related]
3. Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats.
Ling MH; Chen MC
Acta Biomater; 2013 Nov; 9(11):8952-61. PubMed ID: 23816646
[TBL] [Abstract][Full Text] [Related]
4. Multilayered pyramidal dissolving microneedle patches with flexible pedestals for improving effective drug delivery.
Lau S; Fei J; Liu H; Chen W; Liu R
J Control Release; 2017 Nov; 265():113-119. PubMed ID: 27574991
[TBL] [Abstract][Full Text] [Related]
5. Two-Layer Sustained-Release Microneedles Encapsulating Exenatide for Type 2 Diabetes Treatment.
Liu H; Zhang S; Zhou Z; Xing M; Gao Y
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745827
[TBL] [Abstract][Full Text] [Related]
6. Poly-γ-glutamic acid microneedles with a supporting structure design as a potential tool for transdermal delivery of insulin.
Chen MC; Ling MH; Kusuma SJ
Acta Biomater; 2015 Sep; 24():106-16. PubMed ID: 26102333
[TBL] [Abstract][Full Text] [Related]
7. Study on the fabrication and characterization of tip-loaded dissolving microneedles for transdermal drug delivery.
Zhuang J; Rao F; Wu D; Huang Y; Xu H; Gao W; Zhang J; Sun J
Eur J Pharm Biopharm; 2020 Dec; 157():66-73. PubMed ID: 33059004
[TBL] [Abstract][Full Text] [Related]
8. Tip-loaded fast-dissolving microneedle patches for photodynamic therapy of subcutaneous tumor.
Zhao X; Li X; Zhang P; Du J; Wang Y
J Control Release; 2018 Sep; 286():201-209. PubMed ID: 30056119
[TBL] [Abstract][Full Text] [Related]
9. Long-Acting Phospholipid Gel of Exenatide for Long-Term Therapy of Type II Diabetes.
Hu M; Zhang Y; Xiang N; Zhong Y; Gong T; Zhang ZR; Fu Y
Pharm Res; 2016 Jun; 33(6):1318-26. PubMed ID: 26857900
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of dissolving polymer microneedles for controlled drug encapsulation and delivery: Bubble and pedestal microneedle designs.
Chu LY; Choi SO; Prausnitz MR
J Pharm Sci; 2010 Oct; 99(10):4228-38. PubMed ID: 20737630
[TBL] [Abstract][Full Text] [Related]
11. Advances in microneedle-based transdermal delivery for drugs and peptides.
Aich K; Singh T; Dang S
Drug Deliv Transl Res; 2022 Jul; 12(7):1556-1568. PubMed ID: 34564827
[TBL] [Abstract][Full Text] [Related]
12. Panorama of dissolving microneedles for transdermal drug delivery.
Dalvi M; Kharat P; Thakor P; Bhavana V; Singh SB; Mehra NK
Life Sci; 2021 Nov; 284():119877. PubMed ID: 34384832
[TBL] [Abstract][Full Text] [Related]
13. Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery.
Nasiri MI; Vora LK; Ershaid JA; Peng K; Tekko IA; Donnelly RF
Drug Deliv Transl Res; 2022 Apr; 12(4):881-896. PubMed ID: 34939170
[TBL] [Abstract][Full Text] [Related]
14. Tip-loaded dissolving microneedles for transdermal delivery of donepezil hydrochloride for treatment of Alzheimer's disease.
Kim JY; Han MR; Kim YH; Shin SW; Nam SY; Park JH
Eur J Pharm Biopharm; 2016 Aug; 105():148-55. PubMed ID: 27288938
[TBL] [Abstract][Full Text] [Related]
15. Dissolving microneedle patch for transdermal delivery of human growth hormone.
Lee JW; Choi SO; Felner EI; Prausnitz MR
Small; 2011 Feb; 7(4):531-9. PubMed ID: 21360810
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of a once-weekly formulation of an antidiabetic peptide drug exenatide in an injectable thermogel.
Yu L; Li K; Liu X; Chen C; Bao Y; Ci T; Chen Q; Ding J
J Pharm Sci; 2013 Nov; 102(11):4140-9. PubMed ID: 24114868
[TBL] [Abstract][Full Text] [Related]
17. Current trends in polymer microneedle for transdermal drug delivery.
Ahmed Saeed Al-Japairai K; Mahmood S; Hamed Almurisi S; Reddy Venugopal J; Rebhi Hilles A; Azmana M; Raman S
Int J Pharm; 2020 Sep; 587():119673. PubMed ID: 32739388
[TBL] [Abstract][Full Text] [Related]
18. A long-acting formulation of a polypeptide drug exenatide in treatment of diabetes using an injectable block copolymer hydrogel.
Li K; Yu L; Liu X; Chen C; Chen Q; Ding J
Biomaterials; 2013 Apr; 34(11):2834-42. PubMed ID: 23352120
[TBL] [Abstract][Full Text] [Related]
19. Glucose-Responsive Microparticle-Loaded Dissolving Microneedles for Selective Delivery of Metformin: A Proof-of-Concept Study.
Syafika N; Azis SBA; Enggi CK; Qonita HA; Mahmud TRA; Abizart A; Asri RM; Permana AD
Mol Pharm; 2023 Feb; 20(2):1269-1284. PubMed ID: 36661193
[TBL] [Abstract][Full Text] [Related]
20. In vivo safety assessment, biodistribution and toxicology of polyvinyl alcohol microneedles with 160-day uninterruptedly applications in mice.
Zhang XP; Wang BB; Li WX; Fei WM; Cui Y; Guo XD
Eur J Pharm Biopharm; 2021 Mar; 160():1-8. PubMed ID: 33484865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
